PACS Group, Inc.

PACS Healthcare Medical Care Facilities

PACS Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $5.3 billion, up 29.3% from fiscal 2024. In the quarter to June 2026, revenue grew 9.07%, EPS grew 45.5%, free cash flow grew 220.5% and total debt fell 4.30%, each against the same quarter a year earlier. Revenue growth for three consecutive years; insiders bought in the last twelve months.

46.91 0.84 −1.76%
Market cap
$7.6B
P/E
27.6×
Fwd P/E
16.8×
Dividend yield
—
F-score
7/9
Altman Z
2.00
Beneish M
−2.74
Dividend safety
n/a

PACS Group, Inc. (PACS) P/E ratio

Alert me on P/E ratio

As of 16 October 2026, PACS Group, Inc. (PACS) trades at a P/E ratio of 27.6×. Over the past ten years it has ranged from 9.0× (September 2025) to 102× (November 2024); the current reading is higher than 40% of that period. That is above the Medical Care Facilities industry median of 20.6× and above the Healthcare sector median of 23.0×.

P/E ratio, daily

Embed this chart

Annual newest first

Period P/E ratio Change
FY2025 31.5× (2.26%)
FY2024 32.2× 19.73%
FY2023 26.9× 0.00%
FY2022 26.9× 0.00%
FY2021 26.9× —

Quarterly newest first

Period P/E ratio Change
Jun 2026 25.1× 21.04%
Mar 2026 20.7× (34.15%)
Dec 2025 31.5× 149.81%
Sep 2025 12.6× (16.15%)
10 more quarters

Against its own ten years

Low 9.0× High 102×
Ten-year median 29.3×
Current reading's percentile 40

P/E ratio against peers

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on PACS